Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Start-Up Launches DNA Sequencing-Based Test For Picking Cancer Drugs
Forbes
Wednesday, May 30, 2012 - 11:18am
tags:
DNA sequencing, FoundationOne
Ardea Biosciences gets $7.5M payment as Bayer starts clinical trial of cancer drug candidate
Yahoo/AP
Wednesday, May 30, 2012 - 11:17am
tags:
Ardea, Bayer, BAY 96-9766
Exclusive: GSK eyes replacing Human Genome board: sources
Reuters
Wednesday, May 30, 2012 - 10:29am
tags:
GSK, Human Genome Sciences, M&A, hostile bid
FDA warns of counterfeit version of Teva's Adderall
Yahoo/Fly on the Wall
Wednesday, May 30, 2012 - 10:29am
tags:
FDA, drug counterfeiting, ADHD, Teva Pharmaceuticals, Adderall
NovaBay Ocular Trial Taps Broad Activity Of Its Anti-Infective
Seeking Alpha
Wednesday, May 30, 2012 - 10:28am
tags:
NovaBay, NVC-422, adenoviral conjunctivitis
Sanofi, Novo, Lilly shape up for big insulin fight
Reuters
Wednesday, May 30, 2012 - 10:25am
tags:
Sanofi, Novo Nordisk, Eli Lilly, diabetes, insulin, Lantus
Teva's new CEO off to shaky start
Globes, Israel
Wednesday, May 30, 2012 - 10:24am
tags:
Pharma CEOs, Teva Pharmaceuticals, Jeremy Levin
KV Pharmaceutical contacted by NYSE over 'unusual activity'
Bizjournals.com
Wednesday, May 30, 2012 - 10:23am
tags:
KV Pharmaceutical, NYSE
Analysts: Pronova patent defense of Lovaza may help Amarin's potential triglyceride drug
Yahoo/AP
Wednesday, May 30, 2012 - 10:22am
tags:
Lovaza, Pronova BioPharma ASA, Amarin, patents, GSK, Abbott Laboratories
Bristol Drug Seen Helping Body Attack Lung Cancer: Health
Bloomberg
Wednesday, May 30, 2012 - 10:21am
tags:
Bristol-Myers Squibb, BMS-936558, lung cancer
Is Dendreon's Downgrade Deserved?
Motley Fool
Wednesday, May 30, 2012 - 10:20am
tags:
Dendreon, downgrades, Provenge, prostate cancer, JNJ, Zytiga
Bulls Buy Zalicus As Novartis Collaboration Gains Traction
Seeking Alpha
Wednesday, May 30, 2012 - 10:19am
tags:
Zalicus, Novartis, Sanofi
The House PDUFA Bill Would Do What?
Pharmalot
Tuesday, May 29, 2012 - 5:10pm
tags:
congress, FDA, PDUFA
Cell Therapeutics' JAK2 Inhibitor Acquisition Is A Smart Pick-Up
Seeking Alpha
Tuesday, May 29, 2012 - 5:09pm
tags:
Cell Therapeutics, JAK inhibitors, Novartis, Pfizer, Onyx, Incyte, pacritinib
A New Look At Galena's NeuVax While Lowering Analyst's Raised Red Flags
Seeking Alpha
Tuesday, May 29, 2012 - 5:08pm
tags:
Galena Biopharma, NeuVax
Merck Suffers Same Flaw As Facebook
Seeking Alpha
Tuesday, May 29, 2012 - 4:48pm
tags:
Merck, Facebook, Ampio Pharmaceuticals, Catalyst Pharmaceutical Partners
Johnson & Johnson says FDA did not approve once-per-day version of HIV pill Prezista
Yahoo/AP
Tuesday, May 29, 2012 - 4:48pm
tags:
FDA, HIV, JNJ, Prezista
Teva won't launch generic Lipitor, Economic Times says
Yahoo/Fly on the Wall
Tuesday, May 29, 2012 - 4:47pm
tags:
generics, Lipitor, Teva Pharmaceuticals, Pfizer
Does Pfizer Have Institutional Stock Support for its Future Product Pipeline?
Wall St. Cheat Sheet
Tuesday, May 29, 2012 - 4:45pm
tags:
Pfizer
Who Should Buy Amylin?
Motley Fool
Tuesday, May 29, 2012 - 4:44pm
tags:
M&A, Amylin, Sanofi, Merck, Bristol-Myers Squibb, Takeda, AstraZeneca

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.